Oxford, MS 3/31/2011 (Penny PayDay) -- Allezoe Medical Holdings (OTC:ALZM) recently announced, in a press release, that it has acquired Organ Transport Systems, Inc. (OTS) from Healthcare of Today, Inc. in an all stock transaction. The acquisition of OTS is the first of several planned acquisitions by Allezoe Medical, according to the release. As I write, shares of Allezoe Medical were down 4 percent at $2.35 per share on heavy volume of nearly 6 million shares compared to its average daily volume of about 4.7 million shares. The company has a market cap of $123 million and a 52-week range between $1.28 and $2.60 per share.As a result of the acquisition, Michael Holder, President, CEO and Director of OTS, and Hyman White, Secretary, Treasurer and Director of OTS, have been appointed to the Board of Directors of ALZM. Mr. Holder will serve as the CEO of Allezoe and Mr. White as its Secretary and Treasurer.
According to the press release, OTS has developed, patented and is in the process of commercializing a portable hypothermic, oxygenated preservation and transport system for human organs. The OTS LifeCradle® technology has been developed to provide a safe and cost effective method to transport human organs for transplant purposes, and improve upon the surprisingly low percentage of donated organs that are actually utilized in transplantation globally, largely due to the failures of the currently available preservation and transport methods.
New Allezoe CEO Michael Holder says, "With the acquisition of Organ Transport by Allezoe Medical, we believe we are positioned to be a biotechnology leader and that our highly skilled leadership and business strategy is suited for introduction to the marketplace. We believe this marriage of opportunity and expertise will prove rewarding for our shareholders as well as the many transplant patients we expect to serve."
For more information, please visit: www.allezoe.com.
No comments:
Post a Comment